Glumin XR 500mg extended-release tablets
Ferron Par Pharmaceuticals
Ingredients in every extended-release tablet
|Metformin HCL||500 mg|
Each package contains
|ATC Level 1||A - Alimentary tract and metabolism|
|ATC Level 2||A10 - Drugs Used in Diabetes|
|ATC Level 3||A10B - Blood Glucose Lowering Drugs; excl. Insulins|
17 YEARS OLD AND ABOVE
Glumin XR® should generally be given once daily with the evening meal and should be started at a low dose, with gradual dose escalation. Subsequent dosage should be adjusted according to the patient’s therapeutic response, using the lowest possible effective dosage. Glumin XR® must be swallowed whole and never crushed or chewed.
In adults, the usual starting dose of Glumin XR® is 500 mg once daily with the evening meal. Maximum recommended daily dose in Adults is 2,000 mg.
Dosage increases should be made in increments of 500 mg weekly, up to a maximum of 2,000 mg once daily with the evening meal. If glycemic control is not achieved on Glumin XR® 2,000 mg once daily, a trial of Glumin XR® 1,000 mg twice daily should be considered.
0 TO 17 YEARS OLD
Safety and effectiveness of Glumin XR® in pediatric patients have not been established. Glumin XR® is not recommended in pediatric patients below the age of 17 years.
As mono– or combined therapy with sulphonylurea in patients with Non-insulin-dependent diabetes mellitus (type 2 diabetes) especially if overweight and whose blood glucose level cannot be controlled by diet alone.
As an adjuvant therapy in insulin-dependent diabetic patients with hardly controlled symptoms.